Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

IOBT

IOBT News

Newswire

10:17

IO Biotech shares surge 10.85% intraday after positive Phase 3 trial results for Cylembio plus Keytruda in advanced melanoma.

08:37

Oncotelic Therapeutics to undergo significant fair-value remeasurement of GMP Bio stake.

16:31

IO Biotech shares surge 26.75% after-hours on positive Cylembio Phase 3 trial results showing improved progression-free survival in melanoma.

12:15

IO Biotech shares jump 21.19% intraday after positive Cylembio Phase 3 trial results show improved survival in melanoma.

10:05

IO Biotech shares surge 19.49% intraday after positive Phase 3 Cylembio trial results presented at Jefferies conference.

View More

About IOBT

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More